Glaukos Corporation

Since its release of iStent^®, a device that can help reduce eye pressure and may reduce reliance on glaucoma medications, Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos combines solid research, creative engineers, and a flexible management style to create products that improve the lives of patients on a global scale.